BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16374509)

  • 61. The isoform-specific stretch of hSos1 defines a new Grb2-binding domain.
    Zarich N; Oliva JL; Jorge R; Santos E; Rojas JM
    Oncogene; 2000 Nov; 19(51):5872-83. PubMed ID: 11127818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of PAK with Rac: determination of a minimum binding domain on PAK.
    Thompson G; Chalk PA; Lowe PN
    Biochem Soc Trans; 1997 Aug; 25(3):509S. PubMed ID: 9388728
    [No Abstract]   [Full Text] [Related]  

  • 63. SH3 ligands in the dopamine D3 receptor.
    Oldenhof J; Ray A; Vickery R; Van Tol HH
    Cell Signal; 2001 Jun; 13(6):411-6. PubMed ID: 11384839
    [TBL] [Abstract][Full Text] [Related]  

  • 64. SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction.
    Birge RB; Knudsen BS; Besser D; Hanafusa H
    Genes Cells; 1996 Jul; 1(7):595-613. PubMed ID: 9078388
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM; Corey SJ
    Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lentivirus Nef specifically activates Pak2.
    Arora VK; Molina RP; Foster JL; Blakemore JL; Chernoff J; Fredericksen BL; Garcia JV
    J Virol; 2000 Dec; 74(23):11081-7. PubMed ID: 11070003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector ACK1.
    Yeow-Fong L; Lim L; Manser E
    FEBS Lett; 2005 Sep; 579(22):5040-8. PubMed ID: 16137687
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes.
    Sawai ET; Baur A; Struble H; Peterlin BM; Levy JA; Cheng-Mayer C
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1539-43. PubMed ID: 8108442
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes.
    Linkermann A; Gelhaus C; Lettau M; Qian J; Kabelitz D; Janssen O
    Biochim Biophys Acta; 2009 Feb; 1794(2):168-76. PubMed ID: 19041431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.
    Hu KQ; Settleman J
    EMBO J; 1997 Feb; 16(3):473-83. PubMed ID: 9034330
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells.
    Ichigotani Y; Yokozaki S; Fukuda Y; Hamaguchi M; Matsuda S
    Cancer Res; 2002 Apr; 62(8):2215-9. PubMed ID: 11956071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.
    Benz C; Ali M; Krystkowiak I; Simonetti L; Sayadi A; Mihalic F; Kliche J; Andersson E; Jemth P; Davey NE; Ivarsson Y
    Mol Syst Biol; 2022 Jan; 18(1):e10584. PubMed ID: 35044719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Generating high-quality protein binders: a large screening effort pays off.
    Nollau P
    Nat Methods; 2011 Jun; 8(7):545-6. PubMed ID: 21716281
    [No Abstract]   [Full Text] [Related]  

  • 74. Functional selection in SH3-mediated activation of the PI3 kinase.
    Aljedani SS; Aldehaiman A; Sandholu A; Alharbi S; Mak VCY; Wu H; Lugari A; Jaremko M; Morelli X; Backer JW; Ladbury JE; Nowakowski M; Cheung LWT; Arold ST
    bioRxiv; 2024 Apr; ():. PubMed ID: 38746413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intercellular transfer of cancer cell invasiveness via endosome-mediated protease shedding.
    Wenzel EM; Pedersen NM; Elfmark LA; Wang L; Kjos I; Stang E; Malerød L; Brech A; Stenmark H; Raiborg C
    Nat Commun; 2024 Feb; 15(1):1277. PubMed ID: 38341434
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma.
    Bousali M; Papatheodoridis G; Paraskevis D; Karamitros T
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442866
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel Roles of SH2 and SH3 Domains in Lipid Binding.
    Sipeki S; Koprivanacz K; Takács T; Kurilla A; László L; Vas V; Buday L
    Cells; 2021 May; 10(5):. PubMed ID: 34068055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy.
    Aloisio A; Nisticò N; Mimmi S; Maisano D; Vecchio E; Fiume G; Iaccino E; Quinto I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918836
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation.
    Zhang P; Liu Y; Lian C; Cao X; Wang Y; Li X; Cong M; Tian P; Zhang X; Wei G; Liu T; Hu G
    Nat Commun; 2020 May; 11(1):2487. PubMed ID: 32427938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.